Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Ovintiv Inc. (DE) (OVV) vs Vaxcyte Inc. Common Stock (PCVX) Price & Performance

Ovintiv Inc. (DE)Trade
Vaxcyte Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Ovintiv Inc. (DE) vs Vaxcyte Inc. Common Stock — how do they compare? Ovintiv Inc. (DE) trades at $66.75 (market cap $18.44B), while Vaxcyte Inc. Common Stock trades at $67.37 (market cap $10.51B). The key difference: Ovintiv Inc. (DE) is the larger of the two by market cap, and Ovintiv Inc. (DE) pays a 1.8% dividend while Vaxcyte Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Ovintiv Inc. (DE) for 6 Days and Vaxcyte Inc. Common Stock for 0 Days on average.

OVVPCVX
Market Cap
$18.44B$10.51B
Volume
3,495,7252,644,694
Sector
EnergyHealth
52-Week High
$66.97$73.82
52-Week Low
$35.97$40.32
Typical Hold Time
6 Days0 Days
Enterprise Value
$22.77B$9.14B
Dividend Yield
1.8%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Ovintiv Inc. (DE)

OVV trades at $66.66, up 2.36% today, with a bullish technical outlook supported by moving averages and strong analyst consensus. The company reported mixed Q2 2026 earnings, missing EPS estimates but showing robust revenue growth. Recent news highlights expansion in Permian and Montney assets, share buybacks, and strong free cash flow generation, positioning the stock for potential upside.

The outlook for OVV is positive, driven by operational strength and strategic acquisitions, though risks include commodity price volatility and natural gas headwinds. With a consensus price target of $76.00 and no sell ratings, Wall Street sentiment remains bullish, offering a favorable risk-reward profile for investors seeking energy exposure.

Vaxcyte Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

OVV

No sentiment data available yet.

PCVX
100% Buy0% Sell
Avg holding period · 0 Days

About Ovintiv Inc. (DE)

Ovintiv explores for and produces oil and natural gas in North America. Its operations are concentrated in major U.S. and Canadian resource basins.

Read more on OVV →

About Vaxcyte Inc. Common Stock

Vaxcyte, Inc. is a clinical-stage vaccine company that engineers protein-based vaccines to prevent bacterial diseases such as invasive pneumococcal disease, using its proprietary cell-free protein synthesis platform to develop candidates including the pneumococcal conjugate vaccines VAX-31 and VAX-24.

Read more on PCVX →